Yonhap Infomax NewsLotte Biologics secures CDMO contract with Japan-based global pharmaceutical firm for anticancer drug development and production, aiming to strengthen its competitive position in global biopharmaceutical markets including Japan through enhanced collaborative partnerships.
#YonhapInfomax #LotteBiologics #CDMO #AnticancerDrug #GlobalPharmaceutical #BiopharmaceuticalDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113881
#YonhapInfomax #LotteBiologics #CDMO #AnticancerDrug #GlobalPharmaceutical #BiopharmaceuticalDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113881
Lotte Biologics Signs CDMO Deal with Japan-Based Global Pharma for Cancer Drug
Lotte Biologics secures CDMO contract with Japan-based global pharmaceutical firm for anticancer drug development and production, aiming to strengthen its competitive position in global biopharmaceutical markets including Japan through enhanced collaborative partnerships.